Moderna and Novo Nordisk are once again in the bad books of the U.K.’s drug marketing watchdog. | Moderna and Novo Nordisk ...
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...
Goldman Sachs analyst Salveen Richter downgraded Moderna (NASDAQ:MRNA) stock from Buy to Neutral, significantly reducing the price target to $51 from the previous $99. Trading at $44.94, the stock has ...
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In ...
The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.